Purple Biotech (PPBT)

• Market cap: $3.84M
• 1 day: -0.24%
• 5 days: 9.84%
• 1 month: -9.03%
• 3 months: -41.08%
• 6 months: -28.92%
• Year to date: -37.42%
• 1 year: -83.41%
• 5 years: -99.51%
• 10 years: -99.96%
• Sector: Healthcare
• Industry: Biotechnology

About: Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Employees: 10